Hywin Holdings Ltd., Leonteq Securities AG and Arta TechFin announced the successful launch of a principal-protected structured product with 9% risk control mechanism linked to the FactSet Hywin Global Health Care Index(TM) (FHGHC). To help Hywin's high-net-worth clients in Asia participate in the long-term upside of this Index, while safeguarding client wealth in a volatile market context, Leonteq deployed its product structuring capabilities and hedging expertise to develop this principal-protected note. ARTA has been engaged as a licensed strategic distribution partner in Hong Kong and in the rest of Asia Pacific region via its partnership network, introducing this unique structured product to family offices and asset managers of different investment strategies.

Inspired by Hywin's healthcare insights and calculated using FactSet's proprietary datasets, the FHGHC tracks more than 40 stocks selected from 19 stock exchanges across 36 sub-sectors of healthcare, with constituent companies such asGSK PLC, BAYER AG, Thermo Fisher, Johnson & Johnson, Pfizer, Daiichi Sankyo, HCA Healthcare Inc, and other leading global healthcare firms. The index represents a diversified and comprehensive benchmark of the global healthcare industry and enables global investors to better capture the investment opportunities in this space.